secwatch.observer — SEC 8-K summary
======================================

Issuer:     Elevance Health, Inc. (ELV)
CIK:        0001156039
Form:       8-K
Filed at:   2025-11-10T23:59:59+00:00
Accession:  0001156039-25-000139
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 7.01
LLM model:  deepseek-v4-flash:cloud@v2

Elevance Health reaffirms FY2025 EPS guidance of $24.70 ($30.00 adj.) and 90.0% benefit expense ratio
--------------------------------------------------------------------------------

- Full-year 2025 GAAP EPS expected ~$24.70, including ~$5.30/sh net unfavorable items.
- Adjusted EPS guidance unchanged at ~$30.00 per diluted share.
- Full-year 2025 benefit expense ratio reaffirmed at approximately 90.0%.
- Reaffirmation reflects current view on market conditions, operational performance, and regulatory landscape.
- Guidance does not include adjustment items beyond those reported in Q3 2025 earnings.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1156039/000115603925000139/0001156039-25-000139-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1156039/000115603925000139/elv-20251110.htm
  HTML page:      https://secwatch.observer/filing/0001156039-25-000139

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer